<DOC>
	<DOCNO>NCT00914277</DOCNO>
	<brief_summary>The primary objective clinical trial study ability SAR407899 increase duration penile erection male patient mild-moderate Erectile Dysfunction . The secondary objective clinical trial study ability SAR407899 shorten increase time erection duration penile erection male patient mild-moderate Erectile Dysfunction determine overall safety tolerability SAR407899 patient .</brief_summary>
	<brief_title>SAR407899 Single-dose Treatment Mild Moderate Erectile Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>male mild moderate erectile dysfunction least 6 month write informed consent diabetes mellitus orthostatic hypotension hypogonadal testosterone level The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Rho-kinase inhibitor</keyword>
	<keyword>male impotence</keyword>
</DOC>